![]() |
市场调查报告书
商品编码
1802960
全球土壤微生物基因组学市场:2032 年预测 - 按技术、应用、最终用户和地区分析Soil Microbial Genomics Market Forecasts to 2032 - Global Analysis By Technology (Next-Generation Sequencing, Polymerase Chain Reaction-based Methods, Microarrays and Other Technologies), Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球土壤微生物基因组学市场预计在 2025 年达到 2.698 亿美元,预计到 2032 年将达到 6.508 亿美元,预测期内的复合年增长率为 13.4%。
土壤微生物基因组学是研究土壤生态系统中多种微生物遗传物质的学科,旨在了解微生物的功能、相互作用及其在养分循环、土壤肥力和环境永续性中的作用。我们利用定序技术和生物资讯学,揭示微生物多样性、代谢途径及其对环境变化的反应。该领域支持农业、碳管理和生物修復领域的进步,优化土壤健康,并为应对粮食安全和气候变迁适应力等全球挑战提供关键见解。
根据ScienceDirect报告,一项使用GeoChip资料的研究从土壤微生物功能基因资料集中识别出总合946个基因、4,342个分类单元、102个门和995个属。
对永续农业的需求不断增加
全球对永续农业的日益关注,从根本上推动了土壤微生物基因组学市场的扩张。农民和农业相关人员越来越认识到,土壤微生物是作物产量、养分循环和生态系统健康的关键决定因素。监管压力和消费者对环保农业实践的需求,迫使农民采用以微生物为基础的解决方案。此外,有益土壤微生物已被证实能够提高作物产量,同时减少对化学肥料的依赖,这吸引了公共和私营部门的大量投资,从而刺激了市场成长。
缺乏标准化通讯协定
缺乏普遍接受的土壤微生物基因体学标准通讯协定是市场发展的一大限制。这项限制导致不同实验室和研究机构在资料收集、处理方法和结果解读方面存在不一致。标准化的缺乏阻碍了研究结果的有效比较,并限制了商业性应用的扩充性。此外,监管机构面临在没有明确行业标准的情况下建立核准框架的挑战,导致产品开发进度缓慢,市场渗透率低。
精密农业一体化
先进的数据分析平台与即时土壤监测系统相结合,如今可以处理复杂的基因组数据集,并为农民提供切实可行的微生物组洞察。人工智慧、物联网感测器和基因组序列测定的融合,使得特异性地点的微生物干预措施能够优化作物产量。此外,这种技术协同效应将促进土壤健康管理预测模型的开发,为农业科技公司创造新的收益来源,并提高基于基因组的农业解决方案的经济可行性。
基因序列测定和数据分析高成本
小农户和开发中地区通常无法承担全面土壤微生物基因组评估的高前期成本。对专业生物资讯学专业知识和计算资源的需求造成了持续的营运成本,并限制了市场准入。此外,定序技术的快速发展使得设备需要频繁升级,进一步增加了整体拥有成本。这种经济障碍可能会限制市场渗透,并将利润集中在资金雄厚的农业公司手中。
新冠疫情最初导致供应链中断和农业研究资金减少,阻碍了土壤微生物基因组学市场的成长。实验室关闭和田间作业受限,严重推迟了正在进行的研究和产品开发进度。然而,这场危机随后激发了人们对粮食安全和永续农业的兴趣,促使农业生物技术投资增加。此外,政府奖励策略还包括对农业创新的资金支持,部分抵消了疫情初期的衝击。疫情最终凸显了韧性粮食生产系统的重要性,并为以土壤微生物为基础的解决方案创造了长期机会。
预计次世代定序仪(NGS)细分市场在预测期内将占据最大份额
预计次世代定序(NGS) 领域将在预测期内占据最大市场占有率,这得益于其相比传统定序方法更卓越的分析能力和成本效益。 NGS 平台能够同时高通量处理多个样本,从而实现全面的土壤微生物组分析,使大规模农业应用具有经济可行性。此外,定序成本的下降和用户友好型 NGS 系统的日益普及,使得农业研究人员和商业相关人员能够轻鬆获得先进的基因组分析能力。
预计农业化学品和农业相关企业部门在预测期内将见证最高的复合年增长率。
随着越来越多的公司认识到土壤微生物基因组学是竞争优势,农化及农业相关企业领域预计将在预测期内实现最高成长率。领先的农化公司正在将微生物组分析纳入其产品开发平臺,以创造更有针对性、更有效的农业解决方案。此外,向生技药品和永续农作物保护产品的转变正在推动微生物基因组学研究的大量研发投入。此外,领先的农化公司与基因组学相关企业之间的策略联盟正在加速创新週期和市场渗透,从而推动该领域的强劲成长动能。
预计北美将在预测期内占据最大的市场占有率,这得益于其发达的农业研究基础设施和较高的技术采用率。该地区受益于政府对农业生物技术研究的大量资助,以及由基因组学公司和学术机构组成的强大生态系统。在有利的法规结构和完善的精密农业的支持下,北美农民积极采用创新农业技术。此外,大型农业化学品和生物技术公司的存在为土壤微生物基因组学的商业化和广泛的市场认可创造了有利环境。
在预测期内,亚太地区预计将呈现最高的复合年增长率,这得益于其农业部门的快速扩张以及政府对永续农业计画的支持力度不断增加。人口压力和日益增长的粮食安全担忧,正在推动该地区对农业创新和提高生产力技术的投资。此外,研究基础设施的改善以及亚洲农民对土壤健康重要性的认识不断提高,也创造了有利的市场条件。国际基因组学公司与本地农业组织之间日益增多的合作,正在加速技术转移和市场开发,使亚太地区成为最具活力的成长地区。
According to Stratistics MRC, the Global Soil Microbial Genomics Market is accounted for $269.8 million in 2025 and is expected to reach $650.8 million by 2032 growing at a CAGR of 13.4% during the forecast period. Soil microbial genomics is the study of genetic material from diverse microorganisms in soil ecosystems to understand their functions, interactions, and roles in nutrient cycling, soil fertility, and environmental sustainability. By leveraging sequencing technologies and bioinformatics, it reveals microbial diversity, metabolic pathways, and responses to environmental changes. This field supports advancements in agriculture, carbon management, and bioremediation, offering critical insights for optimizing soil health and addressing global challenges in food security and climate resilience.
According to ScienceDirect, studies using GeoChip data detected a total of 946 genes, 4,342 taxa, 102 phyla, and 995 genera in soil microbial functional gene datasets.
Growing demand for sustainable agriculture
The escalating global focus on sustainable agricultural practices is fundamentally driving the soil microbial genomics market expansion. Farmers and agricultural stakeholders increasingly recognize soil microbiomes as critical determinants of crop productivity, nutrient cycling, and ecosystem health. Regulatory pressures and consumer demands for environmentally responsible farming methods are compelling agricultural producers to adopt microbiome-based solutions. Moreover, the proven ability of beneficial soil microorganisms to reduce chemical fertilizer dependency while enhancing crop yields is attracting significant investment from both public and private sectors, thereby accelerating market growth.
Lack of standardized protocols
The absence of universally accepted standardized protocols for soil microbial genomics is a significant market restraint. This limitation creates inconsistencies in data collection, processing methodologies, and result interpretation across different laboratories and research institutions. The lack of standardization hampers effective comparison of research findings and limits the scalability of commercial applications. Moreover, regulatory bodies face challenges in establishing approval frameworks without clear industry standards, consequently slowing product development timelines and market adoption rates.
Precision agriculture integration
Advanced data analytics platforms can now process complex genomic datasets alongside real-time soil monitoring systems to provide farmers with actionable microbiome insights. The convergence of artificial intelligence, IoT sensors, and genomic sequencing enables site-specific microbial interventions that optimize crop performance. Moreover, this technological synergy facilitates the development of predictive models for soil health management, creating new revenue streams for agricultural technology companies and enhancing the economic viability of genomic-based farming solutions.
High cost of genomic sequencing & data analysis
Small-scale farmers and developing regions often cannot justify the high upfront costs associated with comprehensive soil microbial genomic assessments. The need for specialized bioinformatics expertise and computational resources creates ongoing operational expenses that limit market accessibility. Moreover, the rapid evolution of sequencing technologies necessitates frequent equipment upgrades, further escalating total ownership costs. This economic barrier restricts market penetration and potentially concentrates benefits among well-funded agricultural enterprises.
The COVID-19 pandemic initially disrupted soil microbial genomics market growth through supply chain interruptions and reduced agricultural research funding. Laboratory closures and restricted fieldwork significantly delayed ongoing studies and product development timelines. However, the crisis subsequently accelerated interest in food security and sustainable agriculture, driving increased investment in agricultural biotechnology. Additionally, government stimulus packages included funding for agricultural innovation, partially offsetting initial setbacks. The pandemic ultimately highlighted the importance of resilient food production systems, creating long-term opportunities for soil microbiome-based solutions.
The next-generation sequencing (NGS) segment is expected to be the largest during the forecast period
The next-generation sequencing (NGS) segment is expected to account for the largest market share during the forecast period due to its superior analytical capabilities and cost-effectiveness compared to traditional sequencing methods. NGS platforms enable comprehensive soil microbiome profiling through high-throughput processing of multiple samples simultaneously, making large-scale agricultural applications economically viable. Moreover, declining sequencing costs and increasing availability of user-friendly NGS systems are democratizing access to advanced genomic analysis capabilities for agricultural researchers and commercial stakeholders.
The agrochemical and agricultural companies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the agrochemical and agricultural companies segment is predicted to witness the highest growth rate as these organizations increasingly recognize soil microbial genomics as a competitive differentiator. Leading agrochemical corporations are integrating microbiome analysis into their product development pipelines to create more targeted and effective agricultural solutions. Additionally, the shift toward biologics and sustainable crop protection products is driving substantial R&D investments in microbial genomics research. Moreover, strategic partnerships between agrochemical giants and genomics companies are accelerating innovation cycles and market penetration, positioning this segment for exceptional growth momentum.
During the forecast period, the North America region is expected to hold the largest market share, driven by substantial agricultural research infrastructure and advanced technological adoption rates. The region benefits from significant government funding for agricultural biotechnology research and a robust ecosystem of genomics companies and academic institutions. North American farmers demonstrate higher willingness to adopt innovative agricultural technologies, supported by favorable regulatory frameworks and established precision agriculture practices. Moreover, the presence of major agrochemical corporations and biotechnology firms creates conducive environment for soil microbial genomics commercialization and widespread market acceptance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rapidly expanding agricultural sectors and increasing government support for sustainable farming initiatives. Growing population pressures and food security concerns are driving regional investments in agricultural innovation and productivity enhancement technologies. Additionally, improving research infrastructure and rising awareness of soil health importance among Asian farmers are creating favorable market conditions. The increasing collaboration between international genomics companies and local agricultural organizations is accelerating technology transfer and market development, positioning Asia Pacific as the most dynamic growth region.
Key players in the market
Some of the key players in Soil Microbial Genomics Market include Novozymes, Bayer, BASF, Corteva, Syngenta, Marrone Bio Innovations, Certis Biologicals, Indigo Ag, AgBiome, Pivot Bio, Ginkgo Bioworks, BioConsortia, Chr. Hansen, Valent BioSciences, Evogene, and Lallemand.
In November 2022, BASF has expanded R&D on biodegradability and soil microbial interactions. Their research advances developing biodegradable products like mulch films that break down in soil via microbial action. They collaborate extensively to understand and improve how materials biodegrade in soil and wastewater treatment systems, aiming to support sustainable agriculture and reduce environmental impact.
In October 2022, Corteva entered a multi-year European distribution agreement with STI Biotechnologie to bring Lactobacillus strains-based biostimulants (Utrisha(TM) Rhizo) to market. These microbial products enhance soil and rhizosphere health, supporting crop resilience and nutrient uptake under varied conditions. Corteva's biologicals pipeline emphasizes sustainable innovation and natural-origin solutions.
Table 13 Global Soil Microbial Genomics Market Outlook, By Other Technologies (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.